Ankur Andrology & Mens Health Profile
Key Indicators
- Authorised Capital ₹ 3.00 Cr
- Paid Up Capital ₹ 9.75 M
- Company Age 12 Year, 10 Months
- Last Filing with ROC 31 Mar 2024
- Revenue Growth %
- Profit Growth -143.17%
- Ebitda -135.92%
- Net Worth -0.59%
- Total Assets -1.72%
About Ankur Andrology & Mens Health
Ankur Andrology & Mens Health Private Limited (AAMHPL) is a Private Limited Indian Non-Government Company incorporated in India on 07 March 2012 and has a history of 12 years and ten months. Its registered office is in Bangaluru, Karnataka, India.
The Company is engaged in the Healthcare Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 3.00 Cr and a paid-up capital of Rs 9.75 M, as per Ministry of Corporate Affairs (MCA) records.
Satya Vasan, Nishita Vasan, and Ritvik Vasan serve as directors at the Company.
Company Details
-
Location
Bangaluru, Karnataka, India
-
Telephone
+91-XXXXXXXXXX
-
Email Address
-
Website
-
Social Media-
Corporate Identity Details
-
CIN/LLPIN
U85110KA2012PTC062872
-
Company No.
062872
-
Company Classification
Private Limited Indian Non-Government Company
-
Incorporation Date
07 Mar 2012
-
Date of AGM
30 Sep 2024
-
Date of Balance Sheet
31 Mar 2024
-
Listing Status
Unlisted
-
ROC Code
Roc Bangalore
Industry
Who are the key members and board of directors at Ankur Andrology & Mens Health?
Board Members (3)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Satya Vasan
|
Director | 07-Mar-2012 | Current |
|
Nishita Vasan
|
Director | 07-Mar-2012 | Current |
|
Ritvik Vasan
|
Director | 07-Mar-2012 | Current |
Financial Performance of Ankur Andrology & Mens Health.
Ankur Andrology & Mens Health Private Limited, for the financial year ended 2020, experienced no change in revenue, with a 0% increase. The company also saw a substantial fall in profitability, with a 143.17% decrease in profit. The company's net worth dipped by a decrease of 0.59%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
|
(FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
|
||||||
| Revenue from Operations |
|
||||||
| Total Assets |
|
||||||
| Profit or Loss |
|
||||||
| Net Worth |
|
||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Ankur Andrology & Mens Health?
In 2020, Ankur Andrology & Mens Health had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
-
Ankur Healthcare (Ongole) Private LimitedSatya Vasan is a mutual person
-
Ankur Healthcare Private Limited
Satya Vasan is a mutual person
-
Essement Biosciences Private LimitedSatya Vasan is a mutual person
Charges (Loans)
There are no open charges registered against the company as per our records.
How Many Employees Work at Ankur Andrology & Mens Health?
Unlock and access historical data on people associated with Ankur Andrology & Mens Health, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Ankur Andrology & Mens Health, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Ankur Andrology & Mens Health's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
_PRIVATE_LIMITED_354462.webp){kind=small}
